P

Pfizer

Makes cancer drugs, vaccines and other medicines

Field Medical Outcomes - Director, Non-MD

Full-TimeUpdated on 10/14/2026Deadline 10/22/26
$176.6k - $294.3k/yr+ 20% bonus target + Share-based long-term incentive program
Senior, Expert
Bachelor's, PharmD, PhD
Washington, USA
RemoteMust be within a two-hour drive of a major airport; travel 40–50% of the time.
Biology & Biotech
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in health science is required.
  • Relevant experience required: 8+ years with a bachelor's degree, 7+ years with a master's degree, or 5+ years with a terminal doctoral degree (PharmD or PhD).
  • Experience in clinical, formulary, or other management; managed care, the pharmaceutical industry, or quality improvement; or data analytics or health economics and outcomes research activities, with demonstrated methodological skills in study design, data analysis, and interpretation in health services research.
  • Significant experience interacting with payers and other organized customers is required.
  • Excellent oral and written communication skills are required.
  • Demonstrated interpersonal skills, including the ability to understand and respond to multiple external and internal customer demands and constructively manage conflict, are required.
  • Strong analytic skills, including creativity and effectiveness in proactively identifying and addressing challenges.
  • Strong comprehension and communication skills, including the ability to communicate large amounts of scientific information clearly and concisely.
  • Ability to organize, prioritize multiple demands, remain flexible, and employ situational leadership skills.
  • Ability to travel, including overnight travel for internal and external customer, industry, and professional society meetings.
  • Ability to operate a company car with a valid U.S. driver's license and regularly fly on airplanes; must be within a two-hour drive of a major airport and able to travel 40–50% of the time.
  • A valid U.S. driver's license and driving record compliant with company standards are required; any DUI/DWI or other impaired-driving citation within the past seven years disqualifies applicants.
  • Ability to work occasional weekends, such as for advisory boards and congress meetings, and to operate a company car and regularly fly for stakeholder, headquarters, and scientific meetings.
  • Candidates must be authorized to work in the United States by any employer and have permanent U.S. work authorization; visa sponsorship is unavailable.
Responsibilities
  • Ensure compliance with all internal and external standard operating procedures, rules, and regulations.
  • Provide objective, scientifically sound medical information about Pfizer medicines and the diseases they treat using pharmacoeconomic models, outcomes tools, educational programs, Health Outcomes Projects and Evaluations, non-interventional studies, and collaborations.
  • Prioritize customer and Pfizer needs to develop and implement objective, scientifically sound real-world evidence-based outcomes tools, including Health Outcomes Projects and Evaluations and educational programs, to identify opportunities to improve patient care, close quality gaps, and address population health management.
  • Serve as the Field Medical Outcomes lead for assigned customers by developing and executing a medical account plan, representing Medical Affairs, sharing customer insights, and identifying collaboration opportunities to improve patient care.
  • Understand study design, methodology, data analysis, and interpretation principles and communicate them to customers.
  • Engage key market stakeholders, including Quality Improvement Organizations, advocacy groups, coalitions, and medical or healthcare associations, to understand population health priorities and identify opportunities aligned with Pfizer Medical objectives.
  • Provide medical support and guidance for health information technology initiatives, including initial assessment, triaging opportunities for review, assessing organizational capabilities and feasibility, and evaluating the clinical relevance of proposed methodologies.
  • Analyze workflows in clinical healthcare information systems to facilitate care processes, reduce care gaps, improve care efficiencies, and maximize quality and population health.
  • Facilitate development of clinical content that reflects the clinical perspective and uses information technology effectively to develop strategy and build tools and resources.
  • Provide expertise on electronic data collection and planning for Field Medical colleagues.
  • Work cross-functionally within Pfizer guidance to identify, design, and deploy health information technology solutions aligned with Pfizer Medical goals for Field Medical use.
  • Support development of health information technology and clinical informatics resources for new product and new indication launches.
  • Maintain, develop, and use clinical informatics capabilities to enable effective collaborations with external customers.
  • Serve on internal teams to increase the impact of Field Medical Outcomes by creating tools, resources, and educational materials for internal and external use.
  • Represent Pfizer Medical Affairs leadership with clinical or professional associations and societies, demonstrating medical professionalism in interactions.
  • Enhance customer recognition of Pfizer Medical through collaborative projects, publications, and healthcare awards.
  • Provide approved medical content about Pfizer products in the designated therapeutic area, focusing primarily on organized customers, including national and regional payers and specialty pharmacy providers.
  • Maintain knowledge of medical and scientific developments in the designated therapeutic area by reviewing literature, tracking the competitive landscape, networking with experts, and attending assigned conferences.
  • Respond to unsolicited customer requests for scientific interpretation of clinical information and pharmacoeconomic impact of product selection to advance formulary decision-making or patient outcomes through appropriate pharmaceutical care.
  • Collaborate compliantly with internal Pfizer colleagues, including Key Account Managers, Account Directors, PHI, Field Medical, Headquarters Medical, CI, AME, and HEOR, to understand assigned customers' outcomes of interest and data-analysis needs.
  • Maintain significant market and customer knowledge in a complex and dynamic marketplace.
  • Manage a significant volume of field-based projects, prioritizing and implementing them successfully while exercising sound judgment in a continuous-improvement environment.
  • Maintain current status for internal training requirements and conduct activities in accordance with relevant policies, procedures, and compliance guidance.
  • Educate healthcare organizations about patient care gaps in alignment with medical strategy to increase understanding of disease states and guideline-based care.
  • Meet leadership-defined expectations for the number of medical stakeholders engaged.
  • Contribute to medical content strategy development and aligned Field Medical tactics based on Pfizer Medical Affairs priorities.
  • Provide territory and customer leadership, serve on Medical, therapeutic-area, or cross-functional committees as appropriate, and act as a mentorship and onboarding partner.
  • Maintain professional licensure and continue professional learning and development.
  • Inform customer decision-making and improve population health through real-world data analytics, pharmacoeconomic analyses, outcomes evaluations, and medical presentations.
  • Educate customers on the clinical and economic impact of Pfizer medicines and products, and provide disease-area, therapeutic-area, or product expertise for designated areas, primarily for integrated healthcare organizations, payers, and specialty pharmacy providers.
  • Plan and execute independent Medical strategy and engagement for assigned customers within a territory, coordinating compliantly with Pfizer colleagues as needed to achieve Medical objectives.
  • Contribute to Medical educational content strategy and execute aligned Field Medical tactics.
  • Maintain effective communication and collaboration among headquarters Medical colleagues, Medical Information, and other Field Medical colleagues.
  • Communicate scientific information through live and virtual presentations, written materials, telephone conversations, and virtual conversations.
  • Integrate clinical, health information technology, market, and account considerations to develop and execute customer-specific projects, collaborations, strategic medical partnerships, and non-interventional studies that advance quality of care and patient outcomes.
  • Improve patient care by centering Medical communications and deliverables on patients and incorporating health literacy and cultural awareness principles.
  • Respond to medical questions about Pfizer products and other Pfizer medicines as appropriate for the designated therapeutic area.
  • Present to payers, managed care organizations, formulary decision-makers, and regional medical advisory boards in accordance with the designated therapeutic area medical strategy.
  • Facilitate communication between regional and national healthcare organizations and headquarters Medical Affairs colleagues, and provide customer insights that contribute to brand medical strategies as appropriate.
  • Facilitate Pfizer-sponsored research projects and studies, potentially including collaborative projects, quality-improvement research, and non-interventional studies.
  • Maintain knowledge of relevant therapeutic areas, disease states, and Pfizer medicines; provide therapeutic-area and product information to internal and external stakeholders; serve as a resource for Medical Information and customer insights; and share customer viewpoints with Pfizer as appropriate.
Desired Qualifications
  • Previous experience in a field-based medical or outcomes role.
  • Experience analyzing healthcare data, including claims, electronic health records, or other healthcare data.
  • Expertise in clinical informatics or health information technology, including work with claims datasets or electronic health record systems.
  • Residency or fellowship experience.
  • Experience with Microsoft Access, statistical software, or data programming.
  • Experience in the clinical, functional, and technical application of health information technology used in the United States.
  • Experience optimizing or customizing electronic health record platforms, including developing electronic health record clinical solutions.
  • Leadership in innovative project start-up and management.
  • Understanding of the complex business environment of the U.S. healthcare system and emerging healthcare trends.

About the company

Pfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Get referred to Pfizer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Newer drugs carry the business: launched and acquired products grew 18% operationally in Pfizer's August 2026 quarterly report.
  • The outlook improved: in August 2026, Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion.
  • Vaccine scientists get room to grow: Pfizer's $470 million Pearl River, New York research expansion is designed for 370 workers.

What critics are saying

  • Expect more site cuts: in November 2025, Pfizer moved to shrink Swiss staff from about 300 to roughly 70.
  • Generics will erase sales: Pfizer expects patent losses to cut $17 billion to $18 billion of yearly revenue through 2028.
  • Pfizer is chasing obesity leaders: Metsera's monthly shot showed 12.3% weight loss at 28 weeks in February 2026 data.

What makes Pfizer unique

  • Pfizer bought its way into cancer: its Seagen buyout added antibody-drug conjugates, which carry chemotherapy straight to tumors.
  • Pfizer is betting on monthly obesity shots: Metsera's berobenatide is dosed once a month, unlike weekly Wegovy and Zepbound.
  • Pfizer leans on one partnered heart drug: blood thinner Eliquis, sold with Bristol Myers Squibb, brings about 14% of revenue.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-3%

2 year growth

-3%
Yahoo Finance
Oct 19th, 2026
Five low-beta dividend stocks: Pfizer yields 5.83%, Coca-Cola raises payout since 1999

Five defensive dividend stocks offer income with less volatility than the broader market, according to a 24/7 Wall St. analysis. All five have a beta well below 1, meaning they have historically moved less than the market. Pfizer leads with a forward yield of 5.83% at $29.49 a share. AT&T yields 4.77% at $23.27, and its $1.11 dividend uses about 42% of 2026 free cash flow guidance of $18B+. Debt of $144B is its main risk. Dominion Energy yields 4.24%, while Coca-Cola and Colgate-Palmolive each yield 2.27%. Coca-Cola has raised its dividend every year since 1999, and Colgate's next ex-dividend date is October 20, 2026.

Yahoo Finance
Oct 15th, 2026
GSK beats Pfizer as dividend stock: 39% payout vs 89% of free cash flow

GSK looks the better dividend stock than Pfizer, according to a comparison of the two drugmakers, which both face major patent losses before 2030. Pfizer yields 6.3% and GSK 4.1%. Over the twelve months to June 2026, Pfizer paid out 89% of its free cash flow in dividends ($9.79 billion of $10.98 billion), against 39% at GSK (£2.67 billion of £6.90 billion). Pfizer's chief executive officer, Albert Bourla, said the dividend will be maintained even in "the most stretched scenarios." Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion. GSK raised its dividend 17.6% in fiscal 2025 after an earlier cut, and Q2 2026 sales rose 5%. Its main risk is debt: net debt rose to £22 billion after the Nuvalent acquisition.

Yahoo Finance
Oct 14th, 2026
Pfizer's 6% dividend pays investors to wait as oncology pipeline drives growth beyond COVID-19

Pfizer offers a dividend yield of just over 6% while it builds growth beyond its COVID-19 products. The drugmaker declared a quarterly dividend of $0.43 in June 2026, its 351st consecutive quarterly payment. In the second quarter, revenue from launched and acquired products rose 18% year over year. Pfizer raised the midpoint of its full-year guidance, helped by stronger non-COVID sales from drugs such as Eliquis, Padcev, and Vyndaqel. Oncology is the next focus. Pfizer is investing in antibody-drug conjugates and bispecific antibodies, and it entered a global collaboration with Innovent Biologics covering 12 early-stage cancer programs. Not every experimental drug will succeed, but a broader pipeline improves the odds. If new medicines work, the share price could rise on top of the dividend income.

Yahoo Finance
Oct 13th, 2026
Six high-yield dividend stocks fail the payout test, from Ford to Whirlpool's 9.37% mirage

High dividend yields can hide weak payouts, and a four-step test helps separate real income from traps. It checks earnings with one-offs stripped out, full-year free cash flow against dividends, management's explanation, and whether debt funds the gap. Ford yields 4.99% and shows a trailing EPS of -$1.88, caused by $4.2B in one-time charges. Its debt-to-equity of 4.66 leaves the $0.60 dividend exposed to a downturn. Pfizer yields 6.03%, but its free cash flow yield is 5.60%. Clorox's roughly $405M of free cash flow fell short of about $601M in dividends. Whirlpool fails every step. It cut its quarterly dividend from $1.75 to $0.90 in 2025, paid no common dividend in the second quarter of 2026, and its shares are down 59.48% since the end of 2025. 3M and Dow pass, with payouts now covered by cash.

Yahoo Finance
Oct 12th, 2026
UPS, Pfizer, Kraft Heinz and Ford dividends at risk as payouts outstrip earnings

Four blue chip companies, UPS, Pfizer, Kraft Heinz, and Ford, may struggle to sustain their dividends, according to an analysis of their earnings, cash flow, and debt. UPS yields 7.02% and pays out about 121% of its GAAP earnings. Pfizer yields 6.10%, with a GAAP payout ratio of about 226%; its 2025 free cash flow of $9.076 billion fell short of $9.771 billion in dividends. Kraft Heinz yields 6.82%, but its trailing GAAP earnings per share are −$2.88 after $7.4 billion in impairments. Ford yields 4.98% after an $8.162 billion loss in 2025, and its debt-to-equity ratio is 4.66. All four companies say their payouts are safe, and each points to adjusted earnings guidance that covers the dividend.